文献速递眼底病与葡萄膜炎角膜与眼表疾病青光眼

肌成纤维细胞转分化:眼伤口愈合与纤维化中的暗黑力量

Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.
PubMed 文献 · Prog Retin Eye Res · 2017-08-12

本文综述肌成纤维细胞在眼纤维化疾病中的病理作用,重点阐述转化生长因子β(TGFβ)驱动的上皮-间质转化(EMT)及肌成纤维细胞过度产生细胞外基质(ECM)和收缩力导致组织架构扭曲的机制,并汇总多条纤维化信号通路作为新型抗纤维化治疗靶点的研究进展。

要点

  • 肌成纤维细胞转分化是眼纤维化疾病的共同特征,可经上皮-间质转化(EMT)发生。
  • TGFβ在肌成纤维细胞转分化中起主要作用,涉及角膜混浊、翼状胬肉、白内障术后囊膜混浊、增殖性玻璃体视网膜病变等多种眼病。
  • 肌成纤维细胞快速产生过量ECM并施加收缩力,导致组织架构扭曲。

核心结论

  • 肌成纤维细胞在眼纤维化疾病中发挥病理作用,TGFβ驱动的转分化及多条纤维化信号通路可能成为新型抗纤维化治疗靶点以减少瘢痕所致的眼部病变。

研究设计与样本

  • 综述,检索范围未在摘要中报告。

主要发现

  • 异常且不受控制的伤口愈合导致无功能的纤维化组织团块,在眼内破坏正常透明的眼组织并导致不可逆视力丧失。
  • 肌成纤维细胞快速产生过量ECM并施加收缩力,导致组织架构扭曲。
  • TGFβ在肌成纤维细胞转分化中起主要作用,并涉及角膜混浊、翼状胬肉、前囊下白内障、后囊膜混浊、增殖性玻璃体视网膜病变、增殖性糖尿病视网膜病变相关的纤维血管膜形成、黄斑下纤维化、青光眼和眼眶纤维化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Wound healing is one of the most complex biological processes to occur in life. Repair of tissue following injury involves dynamic interactions between multiple cell types, growth factors, inflammatory mediators and components of the extracellular matrix (ECM). Aberrant and uncontrolled wound healing leads to a non-functional mass of fibrotic tissue. In the eye, fibrotic disease disrupts the normally transparent ocular tissues resulting in irreversible loss of vision. A common feature in fibrotic eye disease is the transdifferentiation of cells into myofibroblasts that can occur through a process known as epithelial-mesenchymal transition (EMT). Myofibroblasts rapidly produce excessive amounts of ECM and exert tractional forces across the ECM, resulting in the distortion of tissue architecture. Transforming growth factor-beta (TGFβ) plays a major role in myofibroblast transdifferentiation and has been implicated in numerous fibrotic eye diseases including corneal opacification, pterygium, anterior subcapsular cataract, posterior capsular opacification, proliferative vitreoretinopathy, fibrovascular membrane formation associated with proliferative diabetic retinopathy, submacular fibrosis, glaucoma and orbital fibrosis. This review serves to introduce the pathological functions of the myofibroblast in fibrotic eye disease. We also highlight recent developments in elucidating the multiple signaling pathways involved in fibrogenesis that may be exploited in the development of novel anti-fibrotic therapies to reduce ocular morbidity due to scarring.

来源:Prog Retin Eye Res,查看原文。版权归原作者所有。

引用

  1. Shu DY, Lovicu FJ. Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis. Prog Retin Eye Res. 2017. PMID: 28807717. doi:10.1016/j.preteyeres.2017.08.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。